PHASE I, OPEN-LABEL, DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF KETOCONAZOLE ON SINGLE DOSE MIRABEGRON (YM178) ORAL CONTROLLED ABSORPTION SYSTEM (OCAS) IN HEALTHY ADULT SUBJECTS

被引：0
|
作者：
Sawamoto, T. [1 ]
Lee, J. [1 ]
Alak, A. [1 ]
Meijer, J. [2 ]
Roy, M. [1 ]
Zha, J. [1 ]
van Gelderen, M. [2 ]
Marion, A. [3 ]
Keirns, J. [1 ]
机构：
[1] Astellas Global Res Dev, Deerfield, IL USA
[2] Astellas Global Res Dev, Leiderdorp, Netherlands
[3] MDS Pharma Serv US Inc, Omaha, NE USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [1] PHASE I, OPEN-LABEL, DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF REPEAT DOSES OF RIFAMPIN ON THE SINGLE-DOSE PHARMACOKINETICS OF MIRABEGRON (YM178) IN HEALTHY ADULT SUBJECTS
    Sawamoto, T.
    Lee, J.
    Cao, Y.
    Kowalski, D.
    Alak, A.
    Meijer, J.
    van Gelderen, M.
    Harris, S.
    Keirns, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S21 - S22
  • [2] Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: Open-Label Drug-Drug Interaction Study in Healthy Adults
    Chen, Charles
    Cai, Danlin
    Winnett, Claire E.
    Verma, Neeraj
    Preciado, Priscila
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 385 - 385
  • [3] Effect of Multiple Doses of Sparsentan on the Single-Dose Pharmacokinetics of Dapagliflozin: An Open-Label Drug-Drug Interaction Study in Healthy Adults
    Chen, Shang-Chiung
    Cai, Danlin
    Winnett, Claire
    Nguyen, Mai
    Verma, Neeraj
    Liu, Kai
    Preciado, Priscila
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (05): : 535 - 541
  • [4] A phase I, single-sequence, open-label study to evaluate the drug-drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects
    Li, Fengshan
    Lin, Hongda
    Feng, Shiyin
    Cai, Linrui
    Zhang, Lingli
    Feng, Sheng
    Liu, Xiaohong
    Chen, Zhuo
    Zou, Qin
    Wu, Yiwen
    Su, Xu
    Shen, Kai
    Yu, Qin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (07) : 2160 - 2167
  • [5] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF SINGLE AND MULTIPLE DOSES OF RIFAMPIN ON THE PHARMACOKINETICS OF SOTORASIB (AMG 510) IN HEALTHY SUBJECTS.
    Cardona, P.
    Spring, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S80 - S80
  • [6] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF SINGLE AND MULTIPLE DOSES OF RIFAMPIN ON THE PHARMACOKINETICS OF SOTORASIB (AMG 510) IN HEALTHY SUBJECTS.
    Cardona, P.
    Spring, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S31 - S31
  • [7] An Open-Label Investigation into Drug–Drug Interactions Between Multiple Doses of Daclatasvir and Single-Dose Cyclosporine or Tacrolimus in Healthy Subjects
    Marc Bifano
    Robert Adamczyk
    Carey Hwang
    Hamza Kandoussi
    Alan Marion
    Richard J. Bertz
    Clinical Drug Investigation, 2015, 35 : 281 - 289
  • [8] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Hutton, Shauna
    Hellawell, Jennifer
    Lee, Edward
    DRUGS IN R&D, 2022, 22 (02) : 141 - 146
  • [9] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Ashit Trivedi
    Omar Mather
    Silvia Vega
    Shauna Hutton
    Jennifer Hellawell
    Edward Lee
    Drugs in R&D, 2022, 22 : 141 - 146
  • [10] Pharmacokinetics of Single and Multiple Doses of Omega-3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open-Label Study
    Jing, Shan
    Zhang, Zhenxian
    Chen, Xiaowen
    Miao, Rui
    Nilsson, Catarina
    Lin, Yang
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (08): : 985 - 994
12345